Request for Covid-19 Impact Assessment of this Report
The United States Lysosomal Alpha Glucosidase market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Lysosomal Alpha Glucosidase market, reaching US$ million by the year 2028. As for the Europe Lysosomal Alpha Glucosidase landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Lysosomal Alpha Glucosidase players cover Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, and Genzyme Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Lysosomal Alpha Glucosidase market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Glycogen Storage Disease
Pompe Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lysosomal Alpha Glucosidase Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lysosomal Alpha Glucosidase by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lysosomal Alpha Glucosidase by Country/Region, 2017, 2022 & 2028
2.2 Lysosomal Alpha Glucosidase Segment by Type
2.2.1 AT-982
2.2.2 ATB-200
2.2.3 AVRRD-03
2.2.4 JR-162
2.2.5 MOSS-GAA
2.2.6 OXY-2810
2.2.7 Others
2.3 Lysosomal Alpha Glucosidase Sales by Type
2.3.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
2.3.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lysosomal Alpha Glucosidase Sale Price by Type (2017-2022)
2.4 Lysosomal Alpha Glucosidase Segment by Application
2.4.1 Glycogen Storage Disease
2.4.2 Pompe Disease
2.4.3 Others
2.5 Lysosomal Alpha Glucosidase Sales by Application
2.5.1 Global Lysosomal Alpha Glucosidase Sale Market Share by Application (2017-2022)
2.5.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lysosomal Alpha Glucosidase Sale Price by Application (2017-2022)
3 Global Lysosomal Alpha Glucosidase by Company
3.1 Global Lysosomal Alpha Glucosidase Breakdown Data by Company
3.1.1 Global Lysosomal Alpha Glucosidase Annual Sales by Company (2020-2022)
3.1.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Company (2020-2022)
3.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Company (2020-2022)
3.2.1 Global Lysosomal Alpha Glucosidase Revenue by Company (2020-2022)
3.2.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Company (2020-2022)
3.3 Global Lysosomal Alpha Glucosidase Sale Price by Company
3.4 Key Manufacturers Lysosomal Alpha Glucosidase Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lysosomal Alpha Glucosidase Product Location Distribution
3.4.2 Players Lysosomal Alpha Glucosidase Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lysosomal Alpha Glucosidase by Geographic Region
4.1 World Historic Lysosomal Alpha Glucosidase Market Size by Geographic Region (2017-2022)
4.1.1 Global Lysosomal Alpha Glucosidase Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Geographic Region
4.2 World Historic Lysosomal Alpha Glucosidase Market Size by Country/Region (2017-2022)
4.2.1 Global Lysosomal Alpha Glucosidase Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lysosomal Alpha Glucosidase Annual Revenue by Country/Region
4.3 Americas Lysosomal Alpha Glucosidase Sales Growth
4.4 APAC Lysosomal Alpha Glucosidase Sales Growth
4.5 Europe Lysosomal Alpha Glucosidase Sales Growth
4.6 Middle East & Africa Lysosomal Alpha Glucosidase Sales Growth
5 Americas
5.1 Americas Lysosomal Alpha Glucosidase Sales by Country
5.1.1 Americas Lysosomal Alpha Glucosidase Sales by Country (2017-2022)
5.1.2 Americas Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)
5.2 Americas Lysosomal Alpha Glucosidase Sales by Type
5.3 Americas Lysosomal Alpha Glucosidase Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lysosomal Alpha Glucosidase Sales by Region
6.1.1 APAC Lysosomal Alpha Glucosidase Sales by Region (2017-2022)
6.1.2 APAC Lysosomal Alpha Glucosidase Revenue by Region (2017-2022)
6.2 APAC Lysosomal Alpha Glucosidase Sales by Type
6.3 APAC Lysosomal Alpha Glucosidase Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lysosomal Alpha Glucosidase by Country
7.1.1 Europe Lysosomal Alpha Glucosidase Sales by Country (2017-2022)
7.1.2 Europe Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)
7.2 Europe Lysosomal Alpha Glucosidase Sales by Type
7.3 Europe Lysosomal Alpha Glucosidase Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lysosomal Alpha Glucosidase by Country
8.1.1 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lysosomal Alpha Glucosidase Revenue by Country (2017-2022)
8.2 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Type
8.3 Middle East & Africa Lysosomal Alpha Glucosidase Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lysosomal Alpha Glucosidase
10.3 Manufacturing Process Analysis of Lysosomal Alpha Glucosidase
10.4 Industry Chain Structure of Lysosomal Alpha Glucosidase
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lysosomal Alpha Glucosidase Distributors
11.3 Lysosomal Alpha Glucosidase Customer
12 World Forecast Review for Lysosomal Alpha Glucosidase by Geographic Region
12.1 Global Lysosomal Alpha Glucosidase Market Size Forecast by Region
12.1.1 Global Lysosomal Alpha Glucosidase Forecast by Region (2023-2028)
12.1.2 Global Lysosomal Alpha Glucosidase Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lysosomal Alpha Glucosidase Forecast by Type
12.7 Global Lysosomal Alpha Glucosidase Forecast by Application
13 Key Players Analysis
13.1 Amicus Therapeutics Inc
13.1.1 Amicus Therapeutics Inc Company Information
13.1.2 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
13.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Amicus Therapeutics Inc Main Business Overview
13.1.5 Amicus Therapeutics Inc Latest Developments
13.2 Audentes Therapeutics Inc
13.2.1 Audentes Therapeutics Inc Company Information
13.2.2 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
13.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Audentes Therapeutics Inc Main Business Overview
13.2.5 Audentes Therapeutics Inc Latest Developments
13.3 Etubics Corp
13.3.1 Etubics Corp Company Information
13.3.2 Etubics Corp Lysosomal Alpha Glucosidase Product Offered
13.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Etubics Corp Main Business Overview
13.3.5 Etubics Corp Latest Developments
13.4 Genzyme Corp
13.4.1 Genzyme Corp Company Information
13.4.2 Genzyme Corp Lysosomal Alpha Glucosidase Product Offered
13.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Genzyme Corp Main Business Overview
13.4.5 Genzyme Corp Latest Developments
13.5 greenovation Biotech GmbH
13.5.1 greenovation Biotech GmbH Company Information
13.5.2 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Offered
13.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 greenovation Biotech GmbH Main Business Overview
13.5.5 greenovation Biotech GmbH Latest Developments
13.6 Huons Co Ltd
13.6.1 Huons Co Ltd Company Information
13.6.2 Huons Co Ltd Lysosomal Alpha Glucosidase Product Offered
13.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Huons Co Ltd Main Business Overview
13.6.5 Huons Co Ltd Latest Developments
13.7 JCR Pharmaceuticals Co Ltd
13.7.1 JCR Pharmaceuticals Co Ltd Company Information
13.7.2 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Offered
13.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 JCR Pharmaceuticals Co Ltd Main Business Overview
13.7.5 JCR Pharmaceuticals Co Ltd Latest Developments
13.8 Oxyrane Belgium NV
13.8.1 Oxyrane Belgium NV Company Information
13.8.2 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Offered
13.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Oxyrane Belgium NV Main Business Overview
13.8.5 Oxyrane Belgium NV Latest Developments
13.9 Pharming Group NV
13.9.1 Pharming Group NV Company Information
13.9.2 Pharming Group NV Lysosomal Alpha Glucosidase Product Offered
13.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pharming Group NV Main Business Overview
13.9.5 Pharming Group NV Latest Developments
13.10 Sarepta Therapeutics Inc
13.10.1 Sarepta Therapeutics Inc Company Information
13.10.2 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
13.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sarepta Therapeutics Inc Main Business Overview
13.10.5 Sarepta Therapeutics Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Lysosomal Alpha Glucosidase Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lysosomal Alpha Glucosidase Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AT-982
Table 4. Major Players of ATB-200
Table 5. Major Players of AVRRD-03
Table 6. Major Players of JR-162
Table 7. Major Players of MOSS-GAA
Table 8. Major Players of OXY-2810
Table 9. Major Players of Others
Table 10. Global Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
Table 12. Global Lysosomal Alpha Glucosidase Revenue by Type (2017-2022) & ($ million)
Table 13. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2017-2022)
Table 14. Global Lysosomal Alpha Glucosidase Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Table 17. Global Lysosomal Alpha Glucosidase Revenue by Application (2017-2022)
Table 18. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2017-2022)
Table 19. Global Lysosomal Alpha Glucosidase Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Lysosomal Alpha Glucosidase Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Lysosomal Alpha Glucosidase Sales Market Share by Company (2020-2022)
Table 22. Global Lysosomal Alpha Glucosidase Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Lysosomal Alpha Glucosidase Revenue Market Share by Company (2020-2022)
Table 24. Global Lysosomal Alpha Glucosidase Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Lysosomal Alpha Glucosidase Producing Area Distribution and Sales Area
Table 26. Players Lysosomal Alpha Glucosidase Products Offered
Table 27. Lysosomal Alpha Glucosidase Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Lysosomal Alpha Glucosidase Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Lysosomal Alpha Glucosidase Sales Market Share Geographic Region (2017-2022)
Table 32. Global Lysosomal Alpha Glucosidase Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Lysosomal Alpha Glucosidase Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Lysosomal Alpha Glucosidase Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Lysosomal Alpha Glucosidase Sales Market Share by Country/Region (2017-2022)
Table 36. Global Lysosomal Alpha Glucosidase Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Lysosomal Alpha Glucosidase Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
Table 40. Americas Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
Table 42. Americas Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
Table 44. Americas Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Table 46. APAC Lysosomal Alpha Glucosidase Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)
Table 48. APAC Lysosomal Alpha Glucosidase Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Lysosomal Alpha Glucosidase Revenue Market Share by Region (2017-2022)
Table 50. APAC Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
Table 52. APAC Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Table 54. Europe Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
Table 56. Europe Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
Table 58. Europe Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
Table 60. Europe Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Lysosomal Alpha Glucosidase Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Lysosomal Alpha Glucosidase
Table 71. Key Market Challenges & Risks of Lysosomal Alpha Glucosidase
Table 72. Key Industry Trends of Lysosomal Alpha Glucosidase
Table 73. Lysosomal Alpha Glucosidase Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Lysosomal Alpha Glucosidase Distributors List
Table 76. Lysosomal Alpha Glucosidase Customer List
Table 77. Global Lysosomal Alpha Glucosidase Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Lysosomal Alpha Glucosidase Sales Market Forecast by Region
Table 79. Global Lysosomal Alpha Glucosidase Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Lysosomal Alpha Glucosidase Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Lysosomal Alpha Glucosidase Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Lysosomal Alpha Glucosidase Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Lysosomal Alpha Glucosidase Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Lysosomal Alpha Glucosidase Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Lysosomal Alpha Glucosidase Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Lysosomal Alpha Glucosidase Revenue Market Share Forecast by Application (2023-2028)
Table 97. Amicus Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 98. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
Table 99. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Amicus Therapeutics Inc Main Business
Table 101. Amicus Therapeutics Inc Latest Developments
Table 102. Audentes Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 103. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
Table 104. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Audentes Therapeutics Inc Main Business
Table 106. Audentes Therapeutics Inc Latest Developments
Table 107. Etubics Corp Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 108. Etubics Corp Lysosomal Alpha Glucosidase Product Offered
Table 109. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Etubics Corp Main Business
Table 111. Etubics Corp Latest Developments
Table 112. Genzyme Corp Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 113. Genzyme Corp Lysosomal Alpha Glucosidase Product Offered
Table 114. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Genzyme Corp Main Business
Table 116. Genzyme Corp Latest Developments
Table 117. greenovation Biotech GmbH Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 118. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Offered
Table 119. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. greenovation Biotech GmbH Main Business
Table 121. greenovation Biotech GmbH Latest Developments
Table 122. Huons Co Ltd Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 123. Huons Co Ltd Lysosomal Alpha Glucosidase Product Offered
Table 124. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Huons Co Ltd Main Business
Table 126. Huons Co Ltd Latest Developments
Table 127. JCR Pharmaceuticals Co Ltd Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 128. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Offered
Table 129. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. JCR Pharmaceuticals Co Ltd Main Business
Table 131. JCR Pharmaceuticals Co Ltd Latest Developments
Table 132. Oxyrane Belgium NV Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 133. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Offered
Table 134. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Oxyrane Belgium NV Main Business
Table 136. Oxyrane Belgium NV Latest Developments
Table 137. Pharming Group NV Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 138. Pharming Group NV Lysosomal Alpha Glucosidase Product Offered
Table 139. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Pharming Group NV Main Business
Table 141. Pharming Group NV Latest Developments
Table 142. Sarepta Therapeutics Inc Basic Information, Lysosomal Alpha Glucosidase Manufacturing Base, Sales Area and Its Competitors
Table 143. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Offered
Table 144. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Sarepta Therapeutics Inc Main Business
Table 146. Sarepta Therapeutics Inc Latest Developments
List of Figures
Figure 1. Picture of Lysosomal Alpha Glucosidase
Figure 2. Lysosomal Alpha Glucosidase Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lysosomal Alpha Glucosidase Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Lysosomal Alpha Glucosidase Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lysosomal Alpha Glucosidase Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AT-982
Figure 10. Product Picture of ATB-200
Figure 11. Product Picture of AVRRD-03
Figure 12. Product Picture of JR-162
Figure 13. Product Picture of MOSS-GAA
Figure 14. Product Picture of OXY-2810
Figure 15. Product Picture of Others
Figure 16. Global Lysosomal Alpha Glucosidase Sales Market Share by Type in 2021
Figure 17. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2017-2022)
Figure 18. Lysosomal Alpha Glucosidase Consumed in Glycogen Storage Disease
Figure 19. Global Lysosomal Alpha Glucosidase Market: Glycogen Storage Disease (2017-2022) & (K Pcs)
Figure 20. Lysosomal Alpha Glucosidase Consumed in Pompe Disease
Figure 21. Global Lysosomal Alpha Glucosidase Market: Pompe Disease (2017-2022) & (K Pcs)
Figure 22. Lysosomal Alpha Glucosidase Consumed in Others
Figure 23. Global Lysosomal Alpha Glucosidase Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2017-2022)
Figure 25. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application in 2021
Figure 26. Lysosomal Alpha Glucosidase Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Lysosomal Alpha Glucosidase Revenue Market Share by Company in 2021
Figure 28. Global Lysosomal Alpha Glucosidase Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Lysosomal Alpha Glucosidase Revenue Market Share by Geographic Region in 2021
Figure 30. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2017-2022)
Figure 31. Global Lysosomal Alpha Glucosidase Revenue Market Share by Country/Region in 2021
Figure 32. Americas Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)
Figure 33. Americas Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)
Figure 34. APAC Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)
Figure 35. APAC Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)
Figure 36. Europe Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)
Figure 37. Europe Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Lysosomal Alpha Glucosidase Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Lysosomal Alpha Glucosidase Revenue 2017-2022 ($ Millions)
Figure 40. Americas Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021
Figure 41. Americas Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021
Figure 42. United States Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Lysosomal Alpha Glucosidase Sales Market Share by Region in 2021
Figure 47. APAC Lysosomal Alpha Glucosidase Revenue Market Share by Regions in 2021
Figure 48. China Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021
Figure 55. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021
Figure 56. Germany Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Market Share by Country in 2021
Figure 63. Egypt Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Lysosomal Alpha Glucosidase Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Lysosomal Alpha Glucosidase in 2021
Figure 69. Manufacturing Process Analysis of Lysosomal Alpha Glucosidase
Figure 70. Industry Chain Structure of Lysosomal Alpha Glucosidase
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...